Last reviewed · How we verify
Testosterone cypionate (200mg/3ml)
Testosterone cypionate is an androgenic steroid used primarily for testosterone replacement therapy in males with hypogonadism. It is a long-acting injectable form of testosterone that helps to restore normal testosterone levels. The drug is not approved by the FDA, which may limit its availability and use in certain regions. Common side effects include acne, increased hair growth, and mood changes. Due to its androgenic properties, it can also lead to more severe side effects such as liver damage and cardiovascular issues. The lack of FDA approval means that its safety and efficacy have not been fully evaluated in the United States.
At a glance
| Generic name | Testosterone cypionate (200mg/3ml) |
|---|---|
| Sponsor | Leticia Maria Defendi Barboza Marson |
| Drug class | Androgenic steroid |
| Target | Androgen receptor |
| Modality | Small molecule |
| Therapeutic area | Oncology |
| Phase | FDA-approved |
Approved indications
- Deficiency of testosterone biosynthesis
- Delayed puberty
- Hormone receptor positive malignant neoplasm of breast
- Klinefelter's syndrome, XXY
- LHRH Deficiency
- Male hypogonadism
- Menopausal flushing
- Undescended testicle
Common side effects
Drug interactions
- Anticoagulants
- Insulin
- Oral hypoglycemics
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: